Recursion Pharmaceuticals' Grant

Recursion Pharmaceuticals raised a round of funding on May 07, 2018. Investors include Bill & Melinda Gates Foundation.

Recursion Pharmaceuticals leverages biological science, computation and artificial intelligence to provide a platform that discovers treatments for rare genetic disease and other conditions including …

Articles about Recursion Pharmaceuticals' Grant: